New Age Alpha Advisors LLC Decreases Holdings in Cardinal Health, Inc. $CAH

New Age Alpha Advisors LLC trimmed its holdings in shares of Cardinal Health, Inc. (NYSE:CAH) by 29.1% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 47,032 shares of the company’s stock after selling 19,345 shares during the period. New Age Alpha Advisors LLC’s holdings in Cardinal Health were worth $9,665,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the business. Hantz Financial Services Inc. boosted its position in Cardinal Health by 65.9% during the 4th quarter. Hantz Financial Services Inc. now owns 486 shares of the company’s stock worth $100,000 after purchasing an additional 193 shares during the period. Prospera Financial Services Inc boosted its position in Cardinal Health by 2.1% during the 4th quarter. Prospera Financial Services Inc now owns 9,316 shares of the company’s stock worth $1,916,000 after purchasing an additional 192 shares during the period. Catalyst Funds Management Pty Ltd purchased a new stake in Cardinal Health during the 4th quarter worth $308,000. Jefferies Financial Group Inc. boosted its position in Cardinal Health by 43.3% during the 4th quarter. Jefferies Financial Group Inc. now owns 78,736 shares of the company’s stock worth $16,180,000 after purchasing an additional 23,788 shares during the period. Finally, Evoke Wealth LLC purchased a new stake in Cardinal Health during the 4th quarter worth $327,000. 87.17% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CAH has been the subject of a number of research reports. Mizuho upped their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a research report on Friday, February 6th. Leerink Partners reaffirmed an “outperform” rating and set a $275.00 price target on shares of Cardinal Health in a research report on Monday, March 9th. Wells Fargo & Company decreased their price target on shares of Cardinal Health from $256.00 to $245.00 and set an “overweight” rating for the company in a research report on Friday, May 1st. Zacks Research raised shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, February 12th. Finally, Barclays boosted their price objective on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and an average target price of $241.80.

Cardinal Health Price Performance

Shares of CAH stock opened at $200.42 on Monday. Cardinal Health, Inc. has a 12 month low of $137.75 and a 12 month high of $233.60. The firm has a market capitalization of $46.94 billion, a P/E ratio of 30.64, a P/E/G ratio of 1.19 and a beta of 0.53. The company’s fifty day moving average price is $205.21 and its two-hundred day moving average price is $208.82.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, April 30th. The company reported $3.17 EPS for the quarter, topping analysts’ consensus estimates of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the previous year, the business posted $2.35 EPS. The firm’s revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be paid a $0.5158 dividend. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. This represents a $2.06 dividend on an annualized basis and a dividend yield of 1.0%. Cardinal Health’s dividend payout ratio (DPR) is currently 31.19%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.